31 related articles for article (PubMed ID: 36891950)
1. Immune-Related Adverse Events: Pneumonitis.
Zhong L; Altan M; Shannon VR; Sheshadri A
Adv Exp Med Biol; 2020; 1244():255-269. PubMed ID: 32301020
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Adverse Events in Cancer Immunotherapy: Case Studies of CT Patterns.
Bocchini G; Imperato MC; Valente T; Guarino S; Lieto R; Massimo C; Muto E; Romano F; Scaglione M; Sica G; Vitagliano Torre D; Masala S; Bocchino M; Rea G
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535033
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy-induced pneumonitis in non-small cell lung cancer patients: current concern in treatment with immune-check-point inhibitors.
Sun Z; Wang S; Du H; Shen H; Zhu J; Li Y
Invest New Drugs; 2021 Jun; 39(3):891-898. PubMed ID: 33428078
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase inhibitor related pneumonitis in patients with non-small cell lung cancer: Clinical and radiologic characteristics and risk factors.
Hwang HJ; Kim MY; Choi CM; Lee JC
Medicine (Baltimore); 2019 Nov; 98(48):e18131. PubMed ID: 31770246
[TBL] [Abstract][Full Text] [Related]
5. Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Suresh K; Voong KR; Shankar B; Forde PM; Ettinger DS; Marrone KA; Kelly RJ; Hann CL; Levy B; Feliciano JL; Brahmer JR; Feller-Kopman D; Lerner AD; Lee H; Yarmus L; D'Alessio F; Hales RK; Lin CT; Psoter KJ; Danoff SK; Naidoo J
J Thorac Oncol; 2018 Dec; 13(12):1930-1939. PubMed ID: 30267842
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Tohidinezhad F; Bontempi D; Zhang Z; Dingemans AM; Aerts J; Bootsma G; Vansteenkiste J; Hashemi S; Smit E; Gietema H; Aerts HJ; Dekker A; Hendriks LEL; Traverso A; De Ruysscher D
Eur J Cancer; 2023 Apr; 183():142-151. PubMed ID: 36857819
[TBL] [Abstract][Full Text] [Related]
7. Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).
White DA; Schwartz LH; Dimitrijevic S; Scala LD; Hayes W; Gross SH
J Thorac Oncol; 2009 Nov; 4(11):1357-63. PubMed ID: 19745764
[TBL] [Abstract][Full Text] [Related]
8. Immune-induced pneumonia in patients with advanced solid tumors treated with immunotherapy: a real-world assessment.
Wang C; Zhu H; Huang H; Sun Z; Teng Y; Li Y
Future Oncol; 2023 Jan; 19(3):259-270. PubMed ID: 36891950
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials.
Khunger M; Rakshit S; Pasupuleti V; Hernandez AV; Mazzone P; Stevenson J; Pennell NA; Velcheti V
Chest; 2017 Aug; 152(2):271-281. PubMed ID: 28499515
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.
Suresh K; Naidoo J; Lin CT; Danoff S
Chest; 2018 Dec; 154(6):1416-1423. PubMed ID: 30189190
[TBL] [Abstract][Full Text] [Related]
11. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.
Dai Y; Liu S; Zhang Y; Li X; Zhao Z; Liu P; Du Y
J Med Case Rep; 2021 Feb; 15(1):41. PubMed ID: 33522942
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor].
Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Liu X; Wang M; Shi J; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):621-626. PubMed ID: 31650943
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]